Previous Close | 1.26 |
Open | 1.27 |
Bid | 1.10 x 3000 |
Ask | 1.39 x 20000 |
Day's Range | 1.21 - 1.38 |
52 Week Range | 0.12 - 7.80 |
Volume | 609,273 |
Avg. Volume | 3,081,046 |
Market Cap | 7.092M |
Beta | 3.77 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -34.98 |
Earnings Date | Mar 28, 2018 - Apr 2, 2018 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.00 |
TEL AVIV, ISRAEL, April 19, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that its CGuard™ Embolic Prevention ...
TEL AVIV, Israel, April 03, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced preliminary unaudited sales results ...
Stock Monitor: Avinger Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 29, 2018 / Active-Investors.com has just released a free research report on InspireMD, Inc. (NYSE: NSPR ). If you want access ...
Tel Aviv, Israel, March 28, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced the pricing of an underwritten public ...
Tel Aviv, Israel, March 27, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that it intends to offer and sell, ...
Tel Aviv, Israel, March 27, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that it has received regulatory approval ...
When InspireMD Inc (AMEX:NSPR) released its most recent earnings update (31 December 2017), I compared it against two factor: its historical earnings track record, and the performance of its industryRead More...
Patient with severe stenosis, calcification and thrombosis successfully treated with CGuard™ EPS. TEL AVIV, ISRAEL, March 05, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management ...
Signs Exclusive Distributors for Greece and Caribbean Countries. Tel Aviv, Israel, March 01, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular ...
TEL AVIV, ISRAEL, Feb. 27, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced the pricing of an underwritten public ...
Tel Aviv, Israel, Feb. 26, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that it intends to offer and sell, ...
NEW YORK, NY / ACCESSWIRE / February 23, 2018 / U.S. equities recovered on Thursday with the Dow Jones and S&P 500 closing in the green. The Federal Reserve released minutes from their Wednesday meeting ...
Solvit Medical to fund all regulatory, registration and reimbursement submissions. TEL AVIV, ISRAEL, Feb. 22, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies ...
TEL AVIV, ISRAEL, Feb. 20, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced the commercial launch and first sales ...
TEL AVIV, Israel, Feb. 14, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced results for the fourth quarter and ...
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / On Wednesday, U.S. markets failed to continue on Tuesday's gains as investors worried about rising bond yields and interest rates. The Dow Jones Industrial ...
Tel Aviv, Israel, Feb. 07, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced a 1- for-35 reverse split of its common ...
NEW YORK, NY / ACCESSWIRE / February 1, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
TEL AVIV, ISRAEL, Jan. 31, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that its CGuard™ Embolic Prevention ...
TEL AVIV, ISRAEL, Jan. 30, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that its CGuard™ Embolic Prevention ...
TEL AVIV, ISRAEL, Jan. 26, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that its CGuard™ Embolic Prevention ...
NEW YORK, NY / ACCESSWIRE / January 10, 2018 / U.S. markets continued to climb to new record highs as we enter into earnings season. Major financial companies, BlackRock, J.P. Morgan Chase and Wells Fargo, ...